|
Title
|
Publication Date
|
Price
|
Relevance
|
Tivozanib
Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy
|
Feb 2011 |
£315 |
100% |
|
Cutaneous T-cell Lymphoma Therapy Area Pipeline Report
|
Mar 2011 |
£945 |
99% |
|
Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients
|
Nov 2010 |
£315 |
99% |
|
Stem Cells for Cellular Therapy 2010 Market Report
|
Jan 2010 |
£1,625 |
98% |
|
Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report
|
Mar 2011 |
£945 |
98% |
|
Cancer Cell Therapy Markets
|
Mar 2008 |
£2,150 |
97% |
|
Market Analysis -The Emergence of Stem Cell Research & Therapy
|
Mar 2006 |
£220 |
97% |
Stem Cell-Based Therapeutic Delivery
Challenges & Opportunities
|
Dec 2008 |
£945 |
97% |
Non-small Cell Lung Cancer Drug Market in South Korea
Targeted Therapies Offer Hope in Midst of Low Survival Rates and Increasing Incidence
|
Aug 2011 |
£6,325 |
96% |
|
Stem Cell Therapeutics Markets
|
Feb 2009 |
£1,580 |
96% |
|
Understanding Stem Cell Research
|
Jan 2009 |
£155 |
96% |
Stem Cell Therapies and Regenerative Medicine
Current Applications and Future Possibilities
|
Jan 2005 |
£2,760 |
96% |
|
Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market
|
Feb 2011 |
£2,215 |
96% |
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine
Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies
|
Jul 2008 |
£4,805 |
96% |
Squamous Cell Carcinoma - Pipeline Review
H2 2011
|
Aug 2011 |
£315 |
96% |
|
Cell Therapy Markets
|
Jul 2007 |
£2,150 |
95% |
Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D
Equipment, Tools, Technologies, Opportunities & WW Market Outlook
|
Jan 2010 |
£1,450 |
95% |
Stem Cell Technologies
World Market Outlook 2011-2021
|
May 2011 |
£1,499 |
95% |
Adult Stem Cells and iPSCs 2010
Market Report
|
Mar 2010 |
£1,255 |
95% |
|
Stem Cells for Cardiovascular Disease 2009 Market Report
|
Jan 2009 |
£2,000 |
95% |
|
Stem Cells Research
|
Feb 2011 |
£2,845 |
94% |
Translational Regenerative Medicine
Market Prospects 2011-2021
|
Jul 2011 |
£1,499 |
94% |
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
|
Jan 2012 |
£2,525 |
94% |
Cardiovascular Drug Delivery
Technologies, Markets and Companies
|
Jan 2012 |
£1,815 |
94% |
Stem Cell Therapeutics for Oncology
Technologies and Global Markets
|
Mar 2011 |
£3,065 |
94% |
|
Adult Stem Cells Market Trends 2011
|
Jan 2011 |
£1,500 |
94% |
|
US Stem Cell Market Analysis
|
Apr 2011 |
£505 |
94% |
|
Stem Cell Markets
|
Jun 2010 |
£2,150 |
93% |
Advances in the Stem Cell Industry
The future impact of innovation, and an evaluation of the commercial landscape
|
Oct 2009 |
£2,425 |
93% |
|
Drug Delivery Technology: Revolutionizing Cardiovascular Therapies
|
Jul 2007 |
£945 |
93% |
